Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/13/17 → 07/23/19 |
Funding
- MEI Pharma Incorporated: $8,625.00
A Two-Stage, Open-Label Followed by Placebo-Controlled Phase 2 Study of Pracinostat and Azacitidine in Patients with IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated with Hypomethylating Agents
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Schuster, Michael (CoPI)
- Salman, Huda (PI)
- Kiner-Strachan, Bonnie (CoPI)
Project: Research